1. Home
  2. ONCO vs ADXN Comparison

ONCO vs ADXN Comparison

Compare ONCO & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONCO
  • ADXN
  • Stock Information
  • Founded
  • ONCO 2018
  • ADXN 2002
  • Country
  • ONCO United States
  • ADXN Switzerland
  • Employees
  • ONCO N/A
  • ADXN N/A
  • Industry
  • ONCO Biotechnology: Pharmaceutical Preparations
  • ADXN Biotechnology: Pharmaceutical Preparations
  • Sector
  • ONCO Health Care
  • ADXN Health Care
  • Exchange
  • ONCO Nasdaq
  • ADXN Nasdaq
  • Market Cap
  • ONCO 9.4M
  • ADXN 8.0M
  • IPO Year
  • ONCO 2022
  • ADXN N/A
  • Fundamental
  • Price
  • ONCO $0.54
  • ADXN $7.36
  • Analyst Decision
  • ONCO
  • ADXN Strong Buy
  • Analyst Count
  • ONCO 0
  • ADXN 1
  • Target Price
  • ONCO N/A
  • ADXN $30.00
  • AVG Volume (30 Days)
  • ONCO 9.9M
  • ADXN 15.1K
  • Earning Date
  • ONCO 04-10-2025
  • ADXN 03-24-2025
  • Dividend Yield
  • ONCO N/A
  • ADXN N/A
  • EPS Growth
  • ONCO N/A
  • ADXN N/A
  • EPS
  • ONCO N/A
  • ADXN 0.06
  • Revenue
  • ONCO $1,870,605.00
  • ADXN $701,260.00
  • Revenue This Year
  • ONCO N/A
  • ADXN N/A
  • Revenue Next Year
  • ONCO N/A
  • ADXN N/A
  • P/E Ratio
  • ONCO N/A
  • ADXN $1.01
  • Revenue Growth
  • ONCO N/A
  • ADXN N/A
  • 52 Week Low
  • ONCO $0.32
  • ADXN $6.73
  • 52 Week High
  • ONCO $21.40
  • ADXN $27.90
  • Technical
  • Relative Strength Index (RSI)
  • ONCO 43.36
  • ADXN 46.90
  • Support Level
  • ONCO $0.53
  • ADXN $6.73
  • Resistance Level
  • ONCO $0.70
  • ADXN $7.90
  • Average True Range (ATR)
  • ONCO 0.06
  • ADXN 0.38
  • MACD
  • ONCO 0.00
  • ADXN -0.05
  • Stochastic Oscillator
  • ONCO 15.40
  • ADXN 39.55

About ONCO Onconetix Inc.

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.

Share on Social Networks: